Experienced operators investing in and optimizing small-scale SaaS businesses
Accelerate growth of SaaS startups with proven market traction; Rebrand sub-scale SaaS businesses to unlock new customer segments; Strengthen sales capabilities in early-stage tech companies; Improve operational efficiency through leadership and process optimization; Support scaling of tech-enabled services firms with demonstrated demand
Lock 8 Partners primarily focuses on investing in and optimizing small-scale B2B SaaS (Software as a Service) businesses. Their investment strategy emphasizes a hands-on approach, where they actively engage with portfolio companies to enhance operations and drive sustainable value creation. They target lower middle-market companies and aim to achieve tangible results through operational involvement and strategic guidance.
Lock 8 Partners has several key portfolio companies, each with a brief description:
Projector PSA: A platform that streamlines delivery and enhances resource utilization for professional services companies, enabling sustainable growth and scalability. Read more.
Real Life Sciences: Provides data and document anonymization software and services to the life sciences industry, helping to protect patient identity and confidential information while disclosing clinical trial results. Read more.
Relay: Offers a Medicaid workflow solution that assists school districts in reducing administrative burdens by streamlining documentation, accelerating claims submissions, and enhancing program visibility. Read more.
OrgChart: An org chart and workforce planning solution that delivers automated organizational charts as needed. Read more.
Lock 8 Partners has made a total of 2 notable exits. The most recent exit was from Real Life Sciences, which was acquired by MediSpend on January 27, 2025. The exit method for this transaction was an acquisition. Unfortunately, specific details about the second exit were not found in the available sources.
The management team of Lock 8 Partners includes the following members:
Raised $182M in oversubscribed fundraising for Fund III; Portfolio includes Projector PSA, Real Life Sciences, Relay, OrgChart, Virtual Field, Prism PPM, Firm360, and Cgr; Acquired by Workday in 2024